{"id":401108183,"name":"LMH STRATEGIC SOLUTIONS","slug":"lmh-strategic-solutions","totalIncome":3090000,"filings":86,"yearlyIncome":[{"year":2024,"income":570000},{"year":2025,"income":2520000}],"clients":["ORCHARD THERAPEUTICS NORTH AMERICA","AVADEL PHARMACEUTICALS, PLC","PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","MEDICAL DEVICE MANUFACTURERS ASSOCIATION","GLAXOSMITHKLINE LLC","IONIS PHARMACEUTICALS, INC.","ALKERMES, INC.","RARE DISEASE COMPANY COALITION","ALNYLAM PHARMACEUTICALS, INC.","ERISA INDUSTRY COMMITTEE (ERIC)","STEALTH BIOTHERAPEUTICS INC.","NEUROPACE, INC.","PTC THERAPEUTICS, INC.","ACADIA PHARMACEUTICALS","NEUROCRINE BIOSCIENCES, INC.","REGENXBIO INC.","TRAVERE THERAPEUTICS, INC.","BIOMARIN PHARMACEUTICAL, INC.","ARDELYX, INC.","EXELIXIS, INC.","HARMONY BIOSCIENCES","INCYTE CORPORATION","SAVARA INC."],"lobbyists":["ALANNA TEMME","SONIA GOH"],"issues":["HCR","PHA","MMM","TAX"],"clientCount":23,"years":[2024,2025]}